Form 4 for IRD Opus Genetics, Inc.
Accepted 2024-10-24 00:00:00 ET · period of report 2024-10-22 · accession 0000905148-24-002827 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-24 | 2024-10-22 | IRD | Bennett Jean | Dir | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
| D | 2024-10-24 | 2024-10-22 | IRD | Bennett Jean | Dir | A - Grant | $0.00 | +172.9K | 172.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-22 | A | A | 100,000 | $0.00 | 100,000 | D | — | — | (F1) Represents a grant of restricted stock units which vest on the one-year anniversary of the grant date of October 22, 2024, subject to the Reporting Person's continuing service. |
| 2 | Derivative | Stock Option (right to buy) | 2024-10-22 | A | A | 172,874 | $0.00 | 172,874 | D | $1.33 · — to 2034-10-21 | 172,874 Common Stock | (F2) The option will vest in a series of three equal annual installments over the three-year period measured from the grant date of October 22, 2024, subject to the Reporting Person's continuing service. |